Open Access
| Issue |
MATEC Web Conf.
Volume 404, 2024
2024 2nd International Conference on Materials Engineering, New Energy and Chemistry (MENEC 2024)
|
|
|---|---|---|
| Article Number | 04007 | |
| Number of page(s) | 6 | |
| Section | Pharmaceuticals, Environmental Science, and Toxicology | |
| DOI | https://doi.org/10.1051/matecconf/202440404007 | |
| Published online | 24 October 2024 | |
- R. De Matteis, M. B. Flak, M. Gonzalez-Nunez, et al. Aspirin activates resolution pathways to reprogram T cell and macrophage responses in colitis-associated colorectal cancer. Science Advances 8(5) eabl5420 (2022) [CrossRef] [Google Scholar]
- E. Ricciotti, K. J. Wangensteen, G. A. FitzGerald, Aspirin in hepatocellular carcinoma. Cancer research 81(14) 3751-3761 (2021) [CrossRef] [Google Scholar]
- S. Yoshida, N. Ikenaga, S. B. Liu, et al. Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice. Gastroenterology 147(6) 1378-1392 (2014) [CrossRef] [Google Scholar]
- U. Iqbal, B. B. Dennis, A. A. Li, et al. Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis. Hepatology international 13 84-90 (2019) [CrossRef] [Google Scholar]
- T. Li, Z. R. Dong, Z. Y. Guo, et al. Aspirin enhances IFN-α-induced growth inhibition and apoptosis of hepatocellular carcinoma via JAK1/STAT1 pathway. Cancer gene therapy 20(6) 366-374 (2013) [CrossRef] [Google Scholar]
- Z. Y. Xie, M. S. Liu, C. Zhang, et al. Aspirin enhances the sensitivity of hepatocellular carcinoma side population cells to doxorubicin via miR-491/ABCG2. Bioscience reports 38(6) BSR20180854 (2018) [CrossRef] [Google Scholar]
- X. Li, Y. Tai, S. Liu, et al. The targets of aspirin in bladder cancer: bioinformatics analysis. BMC urology 22(1) 168 (2022) [CrossRef] [Google Scholar]
- S. Naito, V. Bilim, K. Yuuki, et al. Glycogen synthase kinase-3β: a prognostic marker and a potential therapeutic target in human bladder cancer. Clinical Cancer Research 16(21) 5124-5132 (2010) [CrossRef] [Google Scholar]
- F. Marampon, G. L. Gravina, V. M. Popov, et al. Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines. International journal of oncology 44(1) 285-294 (2014) [CrossRef] [Google Scholar]
- G. Au-Yeung, F. Lang, W. J. Azar, et al. Selective targeting of cyclin E1-amplified high-grade serous ovarian cancer by cyclin-dependent kinase 2 and AKT inhibition. Clinical Cancer Research 23(7) 1862-1874 (2017) [CrossRef] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.